🔗 Share this article

An underground market for unapproved slimming medications is propelled by social media fitness personalities and vendors on messaging platforms, based on new investigations.

Experimental Drug Acquiring Popularity Online

Retatrutide, which is still in clinical trials, is being promoted by online personalities for its alleged fat-burning properties. Followers are urged to message these profiles directly for source information, while also obtaining discount codes.

Active Trade on Social Networks

Additionally, a robust trade exists on messaging services, where communities with thousands of participants share “before and after” images, injection guides and assertions of next-day UK delivery. Vendors market the substance there before redirecting buyers to WhatsApp for transactions.

Understanding The Experimental Drug

This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help individuals lose up to 25% of their body weight. Referred to as the “triple G”, the substance is being promoted online as the next Ozempic.

Healthcare Professionals Express Worries

However, doctors and pharmacists have warned that the sale of what is still an unlicensed drug in the UK is a cause for concern and could lead to individuals administering products of uncertain source.

Several experts said the popularity for retatrutide could be connected to the increasing price of approved slimming products such as Mounjaro.

Legal Position and Enforcement

Selling the unapproved drug on social media or Telegram is illegal in the United Kingdom, as it is an unlicensed drug that must not be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.

Several influencers try to circumvent the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still breach pharmaceutical, advertising, and customer regulations, potentially leading to fines, legal action or prison.

Service Reaction and Material Removal

Based on the social media company, the platform has removed problematic content and banned related hashtags and search suggestions. The company said it was committed to maintaining the service safe and investing in strengthening enforcement strategies.

Online Trading Activities

Research also found groups with up to nine thousand participants selling the experimental drug using Telegram's built-in search feature, which operates like a online catalog. Typing “retatrutide” immediately displays channels with numerous of users, filled with photos of slimming results, positive testimonials and detailed guides for mixing or injecting at home.

After moments of joining one community, a seller posted WhatsApp details, where the majority of transactions take place. The seller provided an guidebook and promised delivery within 48 hours. When questioned whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. None asked about body mass, medical conditions or previous experience.

Item Information and Pricing

Within these groups, posts display dark colored parcels with postal service labels, claiming to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at home with purified liquid, or pre-filled injectors usually priced at £160 for 20mg. When asked how much time a pen should be used, sellers give conflicting answers ranging from a few weeks to “depends on your body”.

Service Oversight and Security Measures

A spokesperson for Telegram said it actively moderated dangerous content on its service including material that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are administering substances they cannot confirm. Even if the science behind retatrutide is valid, these online versions may not include what they advertise,” said a pharmacy expert, the head of pharmacy at a pharmacy service.

A medical professional of an online medical service linked the increase in demand to recent cost increases for authorized slimming drugs such as Mounjaro. “With prices increasing, patients are using social media. But fake treatments are highly risky. You can’t be certain what’s contained or whether the environment they were made in was clean,” she said.

Her staff has already seen individuals injured by personal administration from unconfirmed suppliers. “We recognize the disappointment, but purchasing from Telegram or communication platforms is taking chances with your health,” stated Wyllie. “These substances could be impure or improperly measured.”

Producer Position

A spokesperson from the pharmaceutical company stated the substance was in third stage clinical trials and had not been evaluated or approved by any regulatory agency globally. “Therefore at this point no one can sell [it] for human use,” they explained, noting that any item “falsely representing itself as a Lilly investigational substance not yet authorized … may expose users to potentially serious medical dangers”.